SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-002085
Filing Date
2020-02-10
Accepted
2020-02-07 17:37:08
Documents
3
Period of Report
2020-02-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atos20200207_8k.htm 8-K 24788
2 EXHIBIT 1.1 ex_171796.htm EX-1.1 207102
3 EXHIBIT 5.1 ex_171797.htm EX-5.1 6395
  Complete submission text file 0001437749-20-002085.txt   239462
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 20588608
SIC: 2834 Pharmaceutical Preparations